Hyperthermia and chemotherapy: When will they be used in the clinical treatment of cancer?
- 30 November 1983
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (11) , 1655-1658
- https://doi.org/10.1016/0277-5379(83)90101-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Thermal enhancement of bleomycin-induced tumour growth delay: the effect of dose fractionationEuropean Journal of Cancer and Clinical Oncology, 1983
- Thermal enhancement of bleomycin-induced growth delay in a squamous carcinoma of CBA/Ht mouseEuropean Journal of Cancer and Clinical Oncology, 1982
- Response of two mouse tumours to hyperthermia with CCNU or melphalanBritish Journal of Cancer, 1982
- The combined effect of bleomycin and hyperthermia on the adenocarcinoma 284 of the C3H mouseEuropean Journal of Cancer and Clinical Oncology, 1981
- Whole Body Hyperthermia: A Phase-l Trial of a Potential Adjuvant to ChemotherapyAnnals of Internal Medicine, 1979
- Combined treatment of a solid tumour by local hyperthermia and actionomycin DBritish Journal of Cancer, 1978
- Systemic thermotherapy: Description of a method and physiologic tolerance in clinical subjectsCancer, 1977
- Clinical Effects of Whole-body Hyperthermia in Advanced MalignancyBMJ, 1974
- Pharmacokinetics and TemperatureJournal of Pharmaceutical Sciences, 1974